The 340B program is failing to provide promised discounts to Americans, with older patients and patients of color disproportionately unable to access discounts on life-saving medication. The program requires pharmaceutical manufacturers to provide huge discounts to safety-net hospitals and their satellite clinics; however, it does very little to ensure these discounts are passed on to patients. Hospitals use their savings to pad their bottom lines while charging patients steep prices for needed care. Large hospital systems often use their 340B savings to expand in affluent, young, and predominantly white communities, leaving communities of color and older Americans behind. Our Health Equity advocates for meaningful reforms to the 340B program that place patients over profits. Read more here.
340B Should Protect Patients
Next
Next